Your browser doesn't support javascript.
loading
Conventional and PD-L1-expressing Regulatory T Cells are Enriched During BCG Therapy and may Limit its Efficacy.
Chevalier, Mathieu F; Schneider, Anna K; Cesson, Valerie; Dartiguenave, Florence; Lucca, Ilaria; Jichlinski, Patrice; Nardelli-Haefliger, Denise; Derré, Laurent.
Afiliação
  • Chevalier MF; Department of Urology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Schneider AK; Department of Urology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Cesson V; Department of Urology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Dartiguenave F; Department of Urology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Lucca I; Department of Urology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Jichlinski P; Department of Urology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Nardelli-Haefliger D; Department of Urology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Derré L; Department of Urology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. Electronic address: laurent.derre@chuv.ch.
Eur Urol ; 74(5): 540-544, 2018 11.
Article em En | MEDLINE | ID: mdl-30033046

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Vacina BCG / Linfócitos T Reguladores / Urotélio / Antígeno B7-H1 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur Urol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Vacina BCG / Linfócitos T Reguladores / Urotélio / Antígeno B7-H1 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur Urol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça